SIMILAR PATTERNS OF AMINO ACIDS FOR 6B94_B_W9TB201_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1c1f | PROTEIN (CONGERIN I) (Congermyriaster) |
PF00337(Gal-bind_lectin) | 7 | HIS A 44ARG A 48ASP A 54ASN A 61TRP A 70GLU A 73ARG A 75 | None | 0.45A | 6b94A-1c1fA:21.66b94B-1c1fA:21.5 | 6b94A-1c1fA:26.836b94B-1c1fA:26.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1gan | GALECTIN-1 (Rhinellaarenarum) |
PF00337(Gal-bind_lectin) | 9 | HIS A 45ASN A 47ARG A 49HIS A 53ASP A 55ASN A 62TRP A 69GLU A 72ARG A 74 | GAL A 136 (-4.0A)GAL A 136 (-3.8A)NDG A 135 ( 2.8A)GAL A 136 (-3.7A)NoneGAL A 136 (-3.7A)GAL A 136 (-3.7A)NDG A 135 ( 2.6A)NDG A 135 (-3.4A) | 0.67A | 6b94A-1ganA:24.66b94B-1ganA:24.4 | 6b94A-1ganA:60.496b94B-1ganA:60.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hlc | HUMAN LECTIN (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 45ASN A 47ARG A 49ASN A 58TRP A 65GLU A 68ARG A 70 | GAL A 998 (-3.8A)GAL A 998 (-4.1A)BGC A 999 ( 2.7A)GAL A 998 (-3.6A)GAL A 998 (-3.7A)BGC A 999 ( 2.8A)BGC A 999 (-4.3A) | 0.50A | 6b94A-1hlcA:23.46b94B-1hlcA:23.2 | 6b94A-1hlcA:30.716b94B-1hlcA:30.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1qmj | BETA-GALACTOSIDE-BINDING LECTIN (Gallus gallus) |
PF00337(Gal-bind_lectin) | 9 | HIS A 44ASN A 46ARG A 48HIS A 52ASP A 54ASN A 61TRP A 68GLU A 71ARG A 73 | None | 0.43A | 6b94A-1qmjA:25.66b94B-1qmjA:25.7 | 6b94A-1qmjA:58.756b94B-1qmjA:58.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1slc | BOVINE GALECTIN-1 (Bos taurus) |
PF00337(Gal-bind_lectin) | 8 | HIS A 44ASN A 46ARG A 48HIS A 52ASN A 61TRP A 68GLU A 71ARG A 73 | GAL A 352 ( 3.8A)GAL A 352 ( 4.2A)NAG A 351 ( 3.1A)GAL A 352 (-3.5A)GAL A 352 ( 3.8A)GAL A 352 (-4.3A)NAG A 351 ( 2.8A)NAG A 351 ( 3.0A) | 0.78A | 6b94A-1slcA:27.46b94B-1slcA:26.5 | 6b94A-1slcA:90.006b94B-1slcA:90.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1slc | BOVINE GALECTIN-1 (Bos taurus) |
PF00337(Gal-bind_lectin) | 8 | HIS A 44ASN A 46ARG A 48HIS A 52ASP A 54ASN A 61TRP A 68GLU A 71 | GAL A 352 ( 3.8A)GAL A 352 ( 4.2A)NAG A 351 ( 3.1A)GAL A 352 (-3.5A)NAG A 355 (-3.4A)GAL A 352 ( 3.8A)GAL A 352 (-4.3A)NAG A 351 ( 2.8A) | 0.47A | 6b94A-1slcA:27.46b94B-1slcA:26.5 | 6b94A-1slcA:90.006b94B-1slcA:90.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ule | GALECTIN-2 (Coprinopsiscinerea) |
PF00337(Gal-bind_lectin) | 6 | HIS A 51ARG A 55ASN A 64TRP A 72GLU A 75ARG A 77 | GAL A 152 (-3.8A)NAG A 153 ( 2.8A)GAL A 152 (-3.9A)GAL A 152 (-3.8A)NAG A 153 ( 2.8A)NAG A 153 (-3.5A) | 0.45A | 6b94A-1uleA:16.16b94B-1uleA:15.2 | 6b94A-1uleA:27.626b94B-1uleA:27.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wlc | CONGERIN II (Congermyriaster) |
PF00337(Gal-bind_lectin) | 7 | HIS A 44ARG A 48ASP A 54ASN A 61TRP A 69GLU A 72ARG A 74 | MES A 777 ( 4.6A)NoneNoneNoneNoneNoneNone | 0.63A | 6b94A-1wlcA:24.06b94B-1wlcA:23.5 | 6b94A-1wlcA:29.896b94B-1wlcA:29.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ww6 | GALECTIN (Agrocybecylindracea) |
PF00337(Gal-bind_lectin) | 6 | HIS A 62ARG A 66ASN A 75TRP A 83GLU A 86ARG A 88 | GAL A 200 (-4.1A)BGC A 201 ( 3.0A)GAL A 200 (-3.7A)GAL A 200 (-3.6A)BGC A 201 ( 3.1A)BGC A 201 ( 4.3A) | 0.73A | 6b94A-1ww6A:14.66b94B-1ww6A:14.2 | 6b94A-1ww6A:20.256b94B-1ww6A:20.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2d3t | 3-KETOACYL-COATHIOLASE (Pseudomonasfragi) |
PF00108(Thiolase_N)PF02803(Thiolase_C) | 5 | HIS C 339ASP C 211ASN C 362GLU C 192ARG C 15 | None | 1.37A | 6b94A-2d3tC:undetectable6b94B-2d3tC:undetectable | 6b94A-2d3tC:12.196b94B-2d3tC:12.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2d6l | LECTIN, GALACTOSEBINDING, SOLUBLE 9 (Mus musculus) |
PF00337(Gal-bind_lectin) | 7 | HIS X 60ASN X 62ARG X 64ASN X 74TRP X 81GLU X 84ARG X 86 | None | 0.54A | 6b94A-2d6lX:19.26b94B-2d6lX:18.8 | 6b94A-2d6lX:33.676b94B-2d6lX:33.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dyc | GALECTIN-4 (Mus musculus) |
PF00337(Gal-bind_lectin) | 6 | HIS A 63ASN A 65ARG A 67ASN A 77TRP A 84GLU A 87 | None | 0.60A | 6b94A-2dycA:18.96b94B-2dycA:18.5 | 6b94A-2dycA:26.126b94B-2dycA:26.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r0h | CGL3 LECTIN (Coprinopsiscinerea) |
PF00337(Gal-bind_lectin) | 5 | HIS A 60ARG A 64ASN A 73GLU A 84ARG A 86 | CTO A 165 (-3.6A)CTO A 165 (-2.6A)CTO A 165 (-4.1A)CTO A 165 (-2.7A)CTO A 165 ( 4.0A) | 0.39A | 6b94A-2r0hA:14.46b94B-2r0hA:13.8 | 6b94A-2r0hA:18.546b94B-2r0hA:18.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wsu | PUTATIVE FIBERPROTEIN (PorcinemastadenovirusB) |
PF00337(Gal-bind_lectin) | 7 | HIS A 435ASN A 437ARG A 439ASN A 451TRP A 459GLU A 462ARG A 464 | None | 0.57A | 6b94A-2wsuA:18.56b94B-2wsuA:17.9 | 6b94A-2wsuA:13.766b94B-2wsuA:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wsu | PUTATIVE FIBERPROTEIN (PorcinemastadenovirusB) |
PF00337(Gal-bind_lectin) | 5 | HIS A 593ASN A 595ASN A 609TRP A 616GLU A 619 | GOL A1686 (-4.0A)NoneGOL A1686 (-3.7A)GOL A1686 (-3.7A)GOL A1686 (-4.2A) | 0.78A | 6b94A-2wsuA:18.56b94B-2wsuA:17.9 | 6b94A-2wsuA:13.766b94B-2wsuA:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ymz | GALECTIN 2 (Gallus gallus) |
PF00337(Gal-bind_lectin) | 5 | HIS A 45ASN A 47ASN A 58TRP A 65ARG A 70 | None | 0.36A | 6b94A-2ymzA:24.16b94B-2ymzA:23.9 | 6b94A-2ymzA:28.356b94B-2ymzA:28.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zgk | ANTI-TUMOR LECTIN (Agrocybeaegerita) |
PF00337(Gal-bind_lectin) | 6 | HIS A 59ARG A 63ASN A 72TRP A 80GLU A 83ARG A 85 | None | 0.77A | 6b94A-2zgkA:15.06b94B-2zgkA:14.4 | 6b94A-2zgkA:19.756b94B-2zgkA:19.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2zhl | GALECTIN-9 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 61ASN A 63ARG A 65ASN A 75TRP A 82GLU A 85ARG A 87 | GAL A1493 ( 3.9A)GAL A1493 (-3.6A)NAG A1494 ( 2.8A)GAL A1493 (-3.9A)GAL A1493 (-3.7A)NAG A1494 ( 2.7A)NAG A1494 (-4.0A) | 0.43A | 6b94A-2zhlA:19.96b94B-2zhlA:19.7 | 6b94A-2zhlA:32.296b94B-2zhlA:32.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ajy | ANCESTRAL CONGERINCON-ANC (-) |
PF00337(Gal-bind_lectin) | 7 | HIS A 44ARG A 48ASP A 54ASN A 61TRP A 68GLU A 71ARG A 73 | GAL A 136 (-3.9A)BGC A 135 ( 2.9A)NoneGAL A 136 (-3.7A)GAL A 136 (-3.5A)BGC A 135 ( 2.6A)BGC A 135 (-4.1A) | 0.81A | 6b94A-3ajyA:22.06b94B-3ajyA:21.9 | 6b94A-3ajyA:43.216b94B-3ajyA:43.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ajz | ANCESTRAL CONGERINCON-ANC (-) |
PF00337(Gal-bind_lectin) | 7 | HIS A 42ARG A 46ASP A 52ASN A 59TRP A 66GLU A 69ARG A 71 | GAL A 133 (-4.0A)BGC A 134 ( 2.8A)NoneGAL A 133 (-3.8A)GAL A 133 (-3.7A)BGC A 134 ( 2.8A)BGC A 134 ( 4.4A) | 0.74A | 6b94A-3ajzA:24.56b94B-3ajzA:24.4 | 6b94A-3ajzA:35.636b94B-3ajzA:35.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ayd | GALECTIN-3 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 158ASN A 160ARG A 162ASN A 174TRP A 181GLU A 184ARG A 186 | GAL A 253 (-3.7A)GAL A 253 (-4.1A)A2G A 252 ( 3.1A)GAL A 253 (-3.9A)GAL A 253 (-3.5A)A2G A 252 (-3.0A)GAL A 256 ( 3.8A) | 0.41A | 6b94A-3aydA:19.46b94B-3aydA:19.1 | 6b94A-3aydA:34.786b94B-3aydA:34.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3dui | BETA-GALACTOSIDE-BINDING LECTIN (Gallus gallus) |
PF00337(Gal-bind_lectin) | 9 | HIS A 45ASN A 47ARG A 49HIS A 53ASP A 55ASN A 62TRP A 69GLU A 72ARG A 74 | None | 0.70A | 6b94A-3duiA:24.36b94B-3duiA:24.6 | 6b94A-3duiA:68.296b94B-3duiA:68.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3goa | 3-KETOACYL-COATHIOLASE (Salmonellaenterica) |
PF00108(Thiolase_N)PF02803(Thiolase_C) | 5 | ASN A 335ASP A 207ASN A 358GLU A 188ARG A 11 | NoneNone CL A 388 (-3.2A)NoneNone | 1.38A | 6b94A-3goaA:undetectable6b94B-3goaA:undetectable | 6b94A-3goaA:10.256b94B-3goaA:10.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i8t | GALECTIN-4 (Mus musculus) |
PF00337(Gal-bind_lectin) | 6 | HIS A 75ASN A 77ARG A 79ASN A 89TRP A 96GLU A 99 | LBT A 165 (-4.0A)GOL A 167 ( 3.2A)LBT A 165 (-2.6A)LBT A 165 (-3.8A)LBT A 165 ( 3.6A)LBT A 165 (-3.0A) | 0.37A | 6b94A-3i8tA:19.46b94B-3i8tA:19.0 | 6b94A-3i8tA:24.496b94B-3i8tA:24.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3m2m | GALECTIN-1 (Rattusnorvegicus) |
PF00337(Gal-bind_lectin) | 9 | HIS A 44ASN A 46ARG A 48HIS A 52ASP A 54ASN A 61TRP A 68GLU A 71ARG A 73 | LAT A 999 (-3.7A)LAT A 999 (-4.1A)LAT A 999 (-3.1A)LAT A 999 (-3.9A)NoneLAT A 999 (-3.7A)LAT A 999 (-3.7A)LAT A 999 (-3.0A)LAT A 999 ( 4.7A) | 0.38A | 6b94A-3m2mA:26.76b94B-3m2mA:25.9 | 6b94A-3m2mA:92.506b94B-3m2mA:92.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n0g | ISOPRENE SYNTHASE (Populus tremulax Populus alba) |
PF01397(Terpene_synth)PF03936(Terpene_synth_C) | 5 | HIS A 237ARG A 116ASP A 112GLU A 196ARG A 156 | None | 1.47A | 6b94A-3n0gA:undetectable6b94B-3n0gA:undetectable | 6b94A-3n0gA:9.206b94B-3n0gA:9.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nv3 | GALECTIN 9 SHORTISOFORM VARIANT (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 235ASN A 237ARG A 239ASN A 248TRP A 255GLU A 258ARG A 260 | GAL A 501 (-3.9A)GAL A 501 (-3.8A)NAG A 502 ( 2.7A)GAL A 501 (-3.8A)GAL A 501 (-3.6A)NAG A 502 ( 2.7A)NAG A 502 (-4.0A) | 0.39A | 6b94A-3nv3A:19.46b94B-3nv3A:18.6 | 6b94A-3nv3A:23.316b94B-3nv3A:23.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ojb | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 5 | HIS A 53ASN A 55ASN A 66TRP A 73ARG A 78 | None | 0.47A | 6b94A-3ojbA:19.76b94B-3ojbA:19.0 | 6b94A-3ojbA:36.676b94B-3ojbA:36.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3vv1 | PROTEIN LEC-6 (Caenorhabditiselegans) |
PF00337(Gal-bind_lectin) | 7 | HIS A 60ASN A 62ARG A 64ASN A 73TRP A 80GLU A 83ARG A 85 | GAL A 201 (-3.8A)GAL A 201 (-3.9A)FUC A 202 (-2.7A)GAL A 201 (-3.8A)GAL A 201 ( 3.8A)FUC A 202 (-2.7A)FUC A 202 ( 4.1A) | 0.41A | 6b94A-3vv1A:18.26b94B-3vv1A:18.1 | 6b94A-3vv1A:31.006b94B-3vv1A:31.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wg1 | GALACTOSIDE-BINDINGLECTIN (Agrocybeaegerita) |
PF00337(Gal-bind_lectin) | 6 | HIS A 62ARG A 66ASN A 75TRP A 83GLU A 86ARG A 88 | LAT A 201 (-3.9A)LAT A 201 (-3.0A)LAT A 201 (-4.1A)LAT A 201 (-3.8A)LAT A 201 (-2.8A)LAT A 201 (-4.4A) | 0.62A | 6b94A-3wg1A:14.86b94B-3wg1A:14.2 | 6b94A-3wg1A:20.126b94B-3wg1A:20.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3wuc | GALECTIN (Xenopus laevis) |
PF00337(Gal-bind_lectin) | 7 | HIS A 47ASN A 49ARG A 51ASP A 57ASN A 64TRP A 71GLU A 74 | GAL A 202 ( 3.9A)GAL A 202 (-4.0A)GLC A 201 (-2.7A)NoneGAL A 202 (-3.9A)GAL A 202 ( 3.7A)GLC A 201 (-2.8A) | 0.42A | 6b94A-3wucA:23.96b94B-3wucA:23.9 | 6b94A-3wucA:42.356b94B-3wucA:42.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3wud | GALECTIN (Xenopus laevis) |
PF00337(Gal-bind_lectin) | 9 | HIS A 45ASN A 47ARG A 49HIS A 52ASP A 55ASN A 62TRP A 69GLU A 72ARG A 74 | GAL A 202 (-3.8A)GAL A 202 (-4.0A)GLC A 201 (-2.7A)SO4 A 203 (-3.9A)NoneGAL A 202 (-3.9A)GAL A 202 (-3.9A)GLC A 201 (-2.7A)GLC A 201 (-4.0A) | 1.00A | 6b94A-3wudA:25.36b94B-3wudA:24.9 | 6b94A-3wudA:60.006b94B-3wudA:60.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wv6 | GALECTIN-9 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 61ASN A 63ARG A 65ASN A 75TRP A 82GLU A 85ARG A 87 | GAL A 402 (-3.9A)GAL A 402 (-3.9A)BGC A 403 (-2.7A)GAL A 402 (-4.0A)GAL A 402 (-3.7A)BGC A 403 (-2.9A)BGC A 403 (-4.1A) | 0.46A | 6b94A-3wv6A:19.46b94B-3wv6A:19.1 | 6b94A-3wv6A:12.936b94B-3wv6A:12.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wv6 | GALECTIN-9 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 235ASN A 237ARG A 239ASN A 248TRP A 255GLU A 258ARG A 260 | GAL A 404 (-4.0A)GAL A 404 (-4.1A)GLC A 405 (-2.7A)GAL A 404 (-3.7A)GAL A 404 ( 3.7A)GLC A 405 ( 2.8A)GLC A 405 (-4.3A) | 0.44A | 6b94A-3wv6A:19.46b94B-3wv6A:19.1 | 6b94A-3wv6A:12.936b94B-3wv6A:12.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3zxe | GALECTIN-7 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 49ASN A 51ARG A 53ASN A 62TRP A 69GLU A 72ARG A 74 | PGZ A 1 (-3.9A)PGZ A 1 (-3.8A)PGZ A 1 (-3.6A)PGZ A 1 (-3.8A)PGZ A 1 (-4.0A)PGZ A 1 (-3.5A)None | 0.63A | 6b94A-3zxeA:20.26b94B-3zxeA:19.5 | 6b94A-3zxeA:38.376b94B-3zxeA:38.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4agv | GALECTIN (Cinachyrella) |
PF00337(Gal-bind_lectin) | 5 | ARG A 47ASN A 60TRP A 68GLU A 71ARG A 73 | None | 0.51A | 6b94A-4agvA:16.96b94B-4agvA:16.2 | 6b94A-4agvA:23.446b94B-4agvA:23.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bmb | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 6 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | LAT A1155 (-3.9A)LAT A1155 (-3.9A)LAT A1155 (-2.7A)LAT A1155 (-3.9A)LAT A1155 (-3.6A)LAT A1155 (-3.0A) | 0.41A | 6b94A-4bmbA:18.96b94B-4bmbA:18.6 | 6b94A-4bmbA:29.576b94B-4bmbA:29.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fqz | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 5 | HIS A 65ASN A 67ARG A 45ASN A 79TRP A 86 | GAL A 401 (-4.0A)GAL A 401 (-4.2A)GAL A 401 (-2.8A)GAL A 401 (-3.8A)GAL A 401 (-3.5A) | 1.33A | 6b94A-4fqzA:18.26b94B-4fqzA:17.8 | 6b94A-4fqzA:16.256b94B-4fqzA:16.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fqz | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 6 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | GAL A 401 (-4.0A)GAL A 401 (-4.2A)BGC A 402 ( 2.5A)GAL A 401 (-3.8A)GAL A 401 (-3.5A)BGC A 402 ( 3.3A) | 0.42A | 6b94A-4fqzA:18.26b94B-4fqzA:17.8 | 6b94A-4fqzA:16.256b94B-4fqzA:16.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fqz | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 229ASN A 231ARG A 233ASN A 242TRP A 249GLU A 252ARG A 254 | None | 0.48A | 6b94A-4fqzA:18.26b94B-4fqzA:17.8 | 6b94A-4fqzA:16.256b94B-4fqzA:16.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hl0 | GALECTIN (Toxascarisleonina) |
PF00337(Gal-bind_lectin) | 5 | HIS A 57ASN A 70TRP A 77GLU A 80ARG A 82 | None | 0.88A | 6b94A-4hl0A:20.56b94B-4hl0A:20.0 | 6b94A-4hl0A:18.036b94B-4hl0A:18.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hl0 | GALECTIN (Toxascarisleonina) |
PF00337(Gal-bind_lectin) | 6 | HIS A 192ASN A 194ARG A 196ASN A 205TRP A 212GLU A 215 | None | 0.29A | 6b94A-4hl0A:20.56b94B-4hl0A:20.0 | 6b94A-4hl0A:18.036b94B-4hl0A:18.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4il1 | CALMODULIN,CALCINEURIN SUBUNITB TYPE 1,SERINE/THREONINE-PROTEIN PHOSPHATASE 2BCATALYTIC SUBUNITALPHA ISOFORM (Rattusnorvegicus) |
PF00149(Metallophos)PF13499(EF-hand_7) | 5 | HIS A 532ASN A 483HIS A 425ASP A 454GLU A 485 | None | 1.35A | 6b94A-4il1A:undetectable6b94B-4il1A:undetectable | 6b94A-4il1A:7.676b94B-4il1A:7.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wvw | GALECTIN (Gallus gallus) |
PF00337(Gal-bind_lectin) | 6 | HIS A 64ASN A 66ARG A 68ASN A 78TRP A 85GLU A 88 | SLT A 201 (-3.9A)SLT A 201 (-3.8A)SLT A 201 (-2.7A)SLT A 201 (-3.9A)SLT A 201 (-3.6A)SLT A 201 (-2.8A) | 0.34A | 6b94A-4wvwA:19.36b94B-4wvwA:18.9 | 6b94A-4wvwA:32.616b94B-4wvwA:32.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xzp | GALECTIN-4 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 6 | HIS A 63ASN A 65ARG A 67ASN A 77TRP A 84GLU A 87 | None | 0.54A | 6b94A-4xzpA:17.56b94B-4xzpA:17.2 | 6b94A-4xzpA:24.526b94B-4xzpA:24.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4y1y | GALECTIN-1 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 9 | HIS A 44ASN A 46ARG A 48HIS A 52ASP A 54ASN A 61TRP A 68GLU A 71ARG A 73 | GAL A 201 (-3.9A)GAL A 201 (-4.4A)6S2 A 202 (-2.8A)GAL A 201 (-4.2A)6S2 A 202 (-3.5A)GAL A 201 (-3.8A)GAL A 201 ( 4.1A)6S2 A 202 (-2.6A)6S2 A 202 (-3.8A) | 0.44A | 6b94A-4y1yA:28.76b94B-4y1yA:26.8 | 6b94A-4y1yA:78.796b94B-4y1yA:78.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4y26 | GALECTIN-7 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 49ASN A 51ARG A 53ASN A 62TRP A 69GLU A 72ARG A 74 | GAL A 201 (-3.9A)GAL A 201 (-4.1A)6S2 A 202 (-2.9A)GAL A 201 (-3.7A)GAL A 201 (-3.5A)6S2 A 202 (-2.8A)6S2 A 202 (-3.5A) | 0.71A | 6b94A-4y26A:20.06b94B-4y26A:19.4 | 6b94A-4y26A:35.516b94B-4y26A:35.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ym3 | GALECTIN-4 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 6 | HIS A 236ASN A 238ARG A 240ASN A 249TRP A 256GLU A 259 | LAT A 401 (-3.9A)LAT A 401 (-4.0A)LAT A 401 (-2.6A)LAT A 401 (-3.7A)LAT A 401 ( 3.8A)LAT A 401 (-3.1A) | 0.35A | 6b94A-4ym3A:18.76b94B-4ym3A:18.2 | 6b94A-4ym3A:24.466b94B-4ym3A:24.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b47 | 2-OXOACID--FERREDOXIN OXIDOREDUCTASEALPHA SUBUNIT (Sulfurisphaeratokodaii) |
PF01558(POR)PF01855(POR_N)PF17147(PFOR_II) | 5 | THR A 353HIS A 48ASN A 37GLU A 39ARG A 600 | None | 1.39A | 6b94A-5b47A:undetectable6b94B-5b47A:undetectable | 6b94A-5b47A:8.566b94B-5b47A:8.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dux | GALECTIN-4 (Homo sapiens) |
no annotation | 6 | HIS B 63ASN B 65ARG B 67ASN B 77TRP B 84GLU B 87 | LAT B 201 (-3.9A)LAT B 201 (-3.8A)LAT B 201 (-2.6A)LAT B 201 (-3.9A)LAT B 201 ( 3.8A)LAT B 201 (-2.4A) | 0.33A | 6b94A-5duxB:19.46b94B-5duxB:19.1 | 6b94A-5duxB:27.696b94B-5duxB:27.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gzg | GALECTIN-8 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 6 | HIS A 65ASN A 67ARG A 69ASN A 79TRP A 86GLU A 89 | LAT A 201 (-3.9A)LAT A 201 (-4.2A)LAT A 201 (-2.3A)LAT A 201 (-3.6A)LAT A 201 (-3.7A)LAT A 201 (-3.0A) | 0.40A | 6b94A-5gzgA:18.76b94B-5gzgA:18.4 | 6b94A-5gzgA:23.176b94B-5gzgA:23.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5h9p | GALECTIN-3 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 158ASN A 160ARG A 162ASN A 174TRP A 181GLU A 184ARG A 186 | TD2 A 301 (-3.8A)TD2 A 301 (-4.0A)TD2 A 301 (-2.8A)TD2 A 301 (-3.8A)TD2 A 301 ( 3.7A)TD2 A 301 (-2.9A)TD2 A 301 (-3.9A) | 0.38A | 6b94A-5h9pA:19.86b94B-5h9pA:19.3 | 6b94A-5h9pA:32.436b94B-5h9pA:32.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jp5 | GALECTIN-5 (Rattusnorvegicus) |
PF00337(Gal-bind_lectin) | 7 | HIS A 57ASN A 59ARG A 61ASN A 70TRP A 77GLU A 80ARG A 82 | PEG A 201 (-3.7A)PEG A 201 ( 4.8A)PEG A 201 (-3.0A)PEG A 201 (-3.6A)PEG A 201 (-2.8A)PEG A 201 (-3.3A)None | 0.45A | 6b94A-5jp5A:19.36b94B-5jp5A:18.7 | 6b94A-5jp5A:25.566b94B-5jp5A:25.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5nfb | GALECTIN-3 (Homo sapiens) |
PF00337(Gal-bind_lectin) | 7 | HIS A 158ASN A 160ARG A 162ASN A 174TRP A 181GLU A 184ARG A 186 | 8VT A 301 (-3.9A)8VT A 301 (-4.0A)8VT A 301 (-2.7A)8VT A 301 (-3.8A)8VT A 301 ( 3.7A)8VT A 301 (-2.7A)8VT A 301 (-3.4A) | 0.34A | 6b94A-5nfbA:19.86b94B-5nfbA:19.4 | 6b94A-5nfbA:37.636b94B-5nfbA:37.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5nlh | GALECTIN (Gallus gallus) |
no annotation | 6 | HIS A 48ASN A 50ARG A 52ASN A 61TRP A 68GLU A 71 | LBT A 201 (-3.5A)LBT A 201 (-3.7A)LBT A 201 (-2.6A)LBT A 201 (-3.9A)LBT A 201 (-3.0A)LBT A 201 (-2.1A) | 0.32A | 6b94A-5nlhA:19.36b94B-5nlhA:18.6 | 6b94A-5nlhA:32.936b94B-5nlhA:32.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6byi | BETA-MANNOSIDASE (Xanthomonascitri) |
no annotation | 5 | THR A 480ASN A 376ARG A 408ASP A 434TRP A 552 | NoneNoneNoneNoneBMA A 901 (-3.7A) | 1.48A | 6b94A-6byiA:undetectable6b94B-6byiA:undetectable | 6b94A-6byiA:undetectable6b94B-6byiA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fof | GALECTIN-3,GALECTIN-3 (Homo sapiens) |
no annotation | 7 | HIS C 158ASN C 160ARG C 162ASN C 174TRP C 181GLU C 184ARG C 186 | LAT C 301 (-3.8A)LAT C 301 (-4.1A)LAT C 301 (-2.7A)LAT C 301 (-3.8A)LAT C 301 (-3.8A)LAT C 301 ( 2.8A)LAT C 301 (-4.0A) | 0.45A | 6b94A-6fofC:19.26b94B-6fofC:18.5 | 6b94A-6fofC:undetectable6b94B-6fofC:undetectable |